News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
Cambridge, UK-based genomics company Inivata has appointed Emma Green Head of Clinical Development and Operations and John Beeler as Vice President of Business Development.
The oncology-focused company is working on ways to use circulating tumour DNA (ctDNA) in clinical applications. It is collaborating with academic institutions, biopharma companies, and clinical centres, using its analysis tool Tam-Seq.
Emma Green comes to Inivata from Cell Therapy Catapult where she was Head of Clinical Operations. She has also worked for Pfizer, Aventis, Sosei UK, and Serentis.
John Beeler most recently served as Director, Theranostics and Business Development at bioMerieux. There, he was responsible for companion diagnostic development and commercialisation agreements with GSK, Novartis and Gilead.